The Latest Breaking News from Stryker

Although Stryker has lagged behind the S&P 500 Index over the past year, Wall Street analysts remain strongly optimistic about the stock's prospects.

Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal business.

March S&P 500 E-Mini futures (ESH25) are up +0.09%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.16% this morning, stabilizing after yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings…

March S&P 500 E-Mini futures (ESH25) are trending up +0.42% this morning, partially rebounding from yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings reports.

Stryker shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

With Stryker gearing up to release its fourth-quarter earnings later this month, analysts expect a significant double-digit growth in earnings.

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends

Stryker shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

This article highlights three MedTech stocks poised for growth in 2025

Stryker has substantially outpaced other medical device stocks over the past year and analysts remain strongly bullish on the stock’s prospects.